Patent · US Expired

Combination preparation for use in dementia

US6037347A · kind A · utility

2Cited by
9References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 25, 1998
Grant dateMar 14, 2000
Priority date
Expiry dateFeb 25, 2018

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a composition which is a pharmaceutical combination preparation comprising a compound which has an acetylcholinesterase-inhibitory action or exhibits muscarinergic action and a compound which increases the endogenous extracellular adenosine level, wherein the combination preparation is suitable for the treatment of dementia. The invention further relates to a process for the production of the combination preparation. The invention additionally relates to a process for treating patients in need of suitable therapy with the combination preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.